{
  "trial_id": "NCT01893047",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "vaginal or caesarean delivery and are feeling well",
      "label": "met"
    },
    {
      "criterion": "first time mothers to avoid confounding variables due to previous positive or negative experiences from expressing milk",
      "label": "met"
    },
    {
      "criterion": "infant will have been born at less than 32.0 weeks of gestation",
      "label": "met"
    },
    {
      "criterion": "mothers will intend to breastfeed and are planning to pump milk on site in the NICU at least once/day",
      "label": "met"
    },
    {
      "criterion": "mothers who smoke, are taking medication that may interfere with breastfeeding, and who have undergone prior breast surgery will not be excluded since they are their own control",
      "label": "unknown"
    },
    {
      "criterion": "with regard to language, mothers must be able to understand the directions and sign a consent form in English",
      "label": "met"
    },
    {
      "criterion": "first time mothers between the ages of 18 and 45 who have had a vaginal or caesarean delivery and are feeling well",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "survival as determined by the attending physician",
      "label": "triggers"
    },
    {
      "criterion": "mothers who have been diagnosed with mastitis will not be recruited for the study",
      "label": "triggers"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly and prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT01893047",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}